In this webinar, Dr. Hendrix will discuss this important milestone in Alzheimer’s disease research and what this decision might mean
June 17, 2021
Today marks an important milestone in Alzheimer’s disease research with the approval by the FDA of Aduhelm (aducanumab) from the
Burlington, MA, June 7, 2021 – Today marks an important milestone in Alzheimer’s disease research with the approval by the FDA
June 1, 2021 When Jay Nothnagle was born in 1974, he was diagnosed with Down syndrome. The advice his young
Question: With the recent change in CDC recommendation to NOT wear masks if fully vaccinated unless there is an underlying
Dr. James Hendrix, LuMind IDSC’s Chief Scientific Officer, along with a team of Down syndrome experts recently published an article
With improved healthcare, the Down syndrome (DS) population is both growing and aging rapidly. However, with longevity comes a very
En abril, 2021, la comunidad de Síndrome de Down celebró la publicación de un artículo en el diario: Translational Science
March 9, 2021 (Burlington, MA): LuMind IDSC Foundation, the National Down Syndrome Society (NDSS), and pharmaceutical leader Eli Lilly and
